Negotiations on the sale of a stake in GLP Pte’s China operations to Guangdong Holdings Ltd. have stalled due to disagreements over deal terms, according to people familiar with the situation.

The study found a sharp increase in the share of patients who received GLP-1 RAs during the study period, with GLP-1 RA use increasing 132.6% from the last six months of 2022 to the last six ...

The study found a sharp increase in the share of patients who received GLP-1 RAs during the study period, with GLP-1 RA use increasing 132.6% from the last six months of 2022 to the last six ...

But in the last few years, with the approval of GLP-1 drugs like Wegovy and Zepbound, more and more people are opting for obesity medicines over gold-standard surgical treatments. “On a ...

A new class of drugs is set to join their ranks and has the potential to eclipse them all—GLP-1 receptor agonists. These drugs mimic the action of a naturally occurring hormone, glucagon-like ...

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their ...

Recently, celebrity Kourtney Kardashian unveiled her GLP-1 Daily capsules, a new product in her popular Lemme vitamin and supplement line. According to its website, the plant-based supplement ...

Share on Pinterest PIKSEL / Getty ImagesNew guidelines for stroke prevention from the American Stroke Association emphasize the benefits of GLP-1 drugs, a balanced diet, regular physical activity ...

Credit: fcm82 / Shutterstock. On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral glucagon-like peptide-1 receptor (GLP-1R) agonist, Rybelsus, which is ...

Structure Therapeutics Inc. (NASDAQ:GPCR) was able to report positive results from its phase 2a study using its GLP-1R agonist GSBR-1290 for the treatment of patients with obesity in June 2024.